J Korean Med Sci.  1988 Dec;3(4):143-149. 10.3346/jkms.1988.3.4.143.

Refractoriness to platelet transfusion after single-donor consecutive platelet transfusions and its relationship to platelet antibodies

Affiliations
  • 1Department of Internal Medicine, College of Medicine, Seoul National University, Korea.

Abstract

In thirty patients with acute leukemia and severe aplastic anemia receiving random single donor platelet transfusions, the development of refractoriness by consecutive platelet transfusions with cytapheresis and its relationship to the appearance of anti-platelet antibodies were investigated. The median number of platelet transfusions inducing refractoriness was 13 times, and 20% of the patients remained unrefractory despite of the repeated multiple platelet transfusions up to 20 to 25 times. The results of anti-platelet antibody tasts by the enzyme-linked immunosorbent assay(ELISA) and immunofluorescent techniques(IFT) showed no statistically significant relationship with the refractoriness (p greater than 0.1). Although there was significant correlation between the results of ELISA and IFT, both tests were insufficient to find out refractoriness even with the use of pooled platelets from multiple donors as target cells. This study shows that 13 single donor platelet transfusions result in refractoriness, that both ELISA and IFT are insufficient to detect refractoriness despite of their significant correlation, and that other methods than these are needed in order to detect alloimmunization.

Keyword

Refractoriness to platelet transfusion; anti-platelet antibody; Random single donor platelet transfusion

MeSH Terms

Adolescent
Adult
Aged
Anemia, Aplastic/therapy
Anemia, Refractory/*etiology
Antibodies/metabolism
*Blood Platelets/immunology
*Blood Transfusion
Female
Humans
Leukemia/therapy
Male
Middle Aged
Antibodies
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr